MENU
+Compare
OCUL
Stock ticker: NASDAQ
AS OF
Oct 16, 04:59 PM (EDT)
Price
$12.20
Change
+$0.26 (+2.18%)
Capitalization
2.53B

OCUL Ocular Therapeutix Forecast, Technical & Fundamental Analysis

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye... Show more

OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OCUL with price predictions
Oct 15, 2025

OCUL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for OCUL turned positive on October 15, 2025. Looking at past instances where OCUL's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where OCUL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 15, 2025. You may want to consider a long position or call options on OCUL as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OCUL advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

OCUL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

OCUL moved below its 50-day moving average on September 30, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OCUL crossed bearishly below the 50-day moving average on September 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCUL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for OCUL entered a downward trend on October 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.271) is normal, around the industry mean (24.545). P/E Ratio (0.000) is within average values for comparable stocks, (55.406). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.185). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (35.714) is also within normal values, averaging (345.728).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. OCUL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCUL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

OCUL is expected to report earnings to fall 3.95% to -37 cents per share on November 10

Ocular Therapeutix OCUL Stock Earnings Reports
Q3'25
Est.
$-0.37
Q2'25
Missed
by $0.04
Q1'25
Missed
by $0.09
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.02
The last earnings report on August 05 showed earnings per share of -38 cents, missing the estimate of -34 cents. With 1.78M shares outstanding, the current market capitalization sits at 2.53B.
A.I. Advisor
published General Information

General Information

a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DGFYX34.110.38
+1.13%
Davis Global Y
TIBCX32.110.22
+0.69%
Thornburg Investment Income Builder C
IPFPX56.21N/A
N/A
Poplar Forest Partners Institutional
TIRHX18.02N/A
N/A
Nuveen Real Estate Sec Sel I
REIZX14.54N/A
N/A
Third Avenue International RE Val Z

OCUL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+6.32%
EYPT - OCUL
64%
Loosely correlated
-10.83%
IDYA - OCUL
57%
Loosely correlated
+4.86%
DNLI - OCUL
54%
Loosely correlated
+7.36%
NUVL - OCUL
53%
Loosely correlated
+5.97%
NRIX - OCUL
53%
Loosely correlated
+12.75%
More